Related content

Conversion towards an atherogenic lipid profile in rheumatoid arthritis patients during long‐term infliximab therapy

By Dahlqvist S. Rantapää   Engstrand S.   Berglin E.   Johnson O  

Scandinavian Journal of Rheumatology, Vol. 35, Iss. 2, 2006-04 ,pp. : 107-111

Informa Healthcare

Access to resources Recommend Favorite

New-onset demyelination induced by infliximab therapy in two rheumatoid arthritis patients

By Tanno Makoto   Nakamura Ichiro   Kobayashi Shunsuke   Kurihara Kumiko   Ito Katsumi  

Clinical Rheumatology, Vol. 25, Iss. 6, 2006-11 ,pp. : 929-933

Springer Publishing Company

Access to resources Recommend Favorite

Rheumatoid nodulosis during methotrexate therapy in a patient with rheumatoid arthritis

By Matsushita Isao   Uzuki Miwa   Matsuno Hiroaki   Sugiyama Eiji   Kimura Tomoastu  

Modern Rheumatology, Vol. 16, Iss. 6, 2006-12 ,pp. : 401-403

Springer Publishing Company

Access to resources Recommend Favorite

Urinary excretion of -GST and albumin in rheumatoid arthritis patients treated with methotrexate or other DMARDs alone or in combination with NSAIDs

By Svendsen K. B.   Ellingsen T.   Bech J. N.   Pfeiffer-Jensen M.   Stengaard-Pedersen K.   Pedersen E. B.  

Scandinavian Journal of Rheumatology, Vol. 34, Iss. 1, 2005-02 ,pp. : 34-39

Informa Healthcare

Access to resources Recommend Favorite

A relationship between pharmacokinetics (PK) and the efficacy of infliximab for patients with rheumatoid arthritis: characterization of infliximab-resistant cases and PK-based modified therapy

By Mori Shunsuke  

Modern Rheumatology, Vol. 17, Iss. 2, 2007-04 ,pp. : 83-91

Springer Publishing Company

Access to resources Recommend Favorite